Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: International Society on Brain and Behaviour: 2nd International Congress on Brain and Behaviour .

Open AccessOral presentation

Antipsychotic drugs and metabolic disorders

Vasileios Athyros

Atherosclerosis and Metabolic Syndrome Units, 2nd Prop. Clinic of Internal Medicine Aristotle University of Thessaloniki, Greece

corresponding author email

from International Society on Brain and Behaviour: 2nd International Congress on Brain and Behaviour
Thessaloniki, Greece. 17–20 November 2005

Annals of General Psychiatry 2006, 5(Suppl 1):S9doi:10.1186/1744-859X-5-S1-S9

Published: 28 February 2006

First paragraph (this article has no abstract)

NCEP-ATP III: The Metabolic Syndrome: Diagnosis is established when at least 3 of these risk factors are present


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.